The Korean Bioengineering Research Institute and the Korean Bioengineering Society are set to enhance research collaboration in the field of biotechnology, including synthetic biology and biofoundries, while fostering the development of emerging researchers.
The Korean Bioengineering Research Institute announced on October 2 that it signed a memorandum of understanding (MOU) with the Korean Bioengineering Society on October 1 at the Jeju International Convention Center to promote the development of emerging researchers and to activate academic and research exchanges in the biotechnology sector.
This agreement aims to strengthen fundamental technology research amid intensifying global competition in biotechnology and to systematically nurture the next generation of researchers who will lead this field.
Under the agreement, the two organizations will work on discovering and nurturing emerging researchers, supporting research activities, identifying, planning, and promoting joint research projects, and establishing a network among industry, academia, and research institutions. They also plan to jointly host special programs and academic events.
They will collaborate on policy research and standardization in the fields of synthetic biology and biofoundries. The organizations agreed to expand researcher exchanges through domestic and international joint projects, as well as to cooperate in publishing and disseminating research results through academic journals and publications. They will also explore ways to support the development of the regional bioindustry by linking the Bioengineering Research Institute's branches with the Korean Bioengineering Society's chapters. The agreement is set to last for three years from the date of signing.
Kwon Seok-yun, president of the Korean Bioengineering Research Institute, stated, "The Korean Bioengineering Society is a leading academic organization where domestic biotechnology researchers actively exchange ideas. Based on the research capabilities and networks of both organizations, we will strengthen the research competitiveness and collaborative foundation in the domestic biotechnology sector." He added, "We will achieve tangible results in nurturing emerging researchers and in collaborative research efforts."
Meanwhile, the Korean Bioengineering Society is hosting the '2026 Korean Bioengineering Society Fall Academic Conference and International Symposium' at the Jeju International Convention Center for three days until today.
The event, themed 'AI STAR (AI Integrated Sustainable Transformations for Advanced Robust Biotechnology),' is expected to attract over 2,000 biotechnology experts from academia and industry, both domestically and internationally. More than 900 recent research findings will be presented across 33 specialized sessions, and an exhibition featuring bio companies and research institutions will also take place.
Keynote speakers include Hui-Min Zhao from the University of Illinois at Urbana-Champaign, Shoji Takeuchi from the University of Tokyo, Gregory Stephanopoulos from the Massachusetts Institute of Technology, and Seok-Chaok from Seoul National University.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.